Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The World’s First Pair of Nikkei 225 Leveraged & Inverse Products (L&Is) Outside of Japan to List on HKEX Tomorrow
-
Tony White Joins MKP Advisors as Partner
-
ForFarmers N.V.: Marloes Roetgerink appointed as member of the Executive Board of ForFarmers N.V.
-
Newegg Hosts Second Annual PC Builder Competition Challenging Contestants to Build the Ultimate Desktop PC System
-
Exor Press Release - 2024 AGM
-
Omdia reveals virtual assistants as leading AI use case driving software revenue in financial services
-
Inside information: MacGregor settles the dispute with a monopile installation vessel customer and Cargotec starts the sales process of MacGregor
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Titian Receives Multi-Year Commitment from Charles River for Mosaic Sample Management Software
-
FICO UK Credit Card Market Report: March 2024
-
Asia-Pacific Textile and Apparel Supply Chain Expo & Summit 2024 (APTEXPO 2024)
-
Toluna Unveils Breakthrough AI-Powered Open-End Analysis that Goes Beyond Words into Meaning
-
Neotech Metals Appoints Vieira as Director & Issues Options
-
SelfDrive Mobility Announces Expansion Into the UK, Scotland, and Ireland Markets, With an All New Web and App Experience!
-
ASRI Expands Global Reach with Patent Filings for Innovative Empathogens, Tryptamines and Phenylalkylamines
-
RTX's Collins Aerospace completes industry first retrofit of Iridium Certus satellite connectivity
-
FERRERO GROUP'S 15th SUSTAINABILITY REPORT DEMONSTRATES SOLID PROGRESS AS COMPANY ACCELERATES EFFORTS TO MEET ITS TARGETS
-
iManage Partnership with HYCU Reinforces iManage Cloud as the Safest Place to Work
-
destream Empowers Content Creators with Exclusive Debit Card Launch
-
Milestone 400th Cessna Citation Latitude Production Rollout Emphasizes Its Leading Position in the Midsize Business Jet Market
-
selectION Announces Initiation of Phase 1b Clinical Trial Evaluating si-544 in Patients with Psoriasis Vulgaris or Psoriatic Arthritis
-
Futu Announces First Quarter 2024 Unaudited Financial Results
-
selectION Announces Initiation of Phase 1b Clinical Trial Evaluating si-544 in Patients with Psoriasis Vulgaris or Psoriatic Arthritis
-
CTP Expands in Romania With 270,000 sqm Warehouse and 30HA Landbank Acquisition
-
Havila Kystruten AS: Invitation to Q1 2024 Earnings Call
-
Invesco Ltd: Form 8.3 - BHP Group Ltd
-
Invesco Ltd: Form 8.3 - DS Smith PLC Public dealing disclosure
-
Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc
-
Invesco Ltd: Form 8.3 - Anglo American PLC
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Pro Kapital Council approved Consolidated Interim Report for I Quarter and 3 Months of 2024 (Unaudited)
-
"Bleach: Brave Souls" to be Released on the Nintendo Switch & Xbox with Thousand-Year Blood War Zenith Summons: Gravitation Featuring New Versions of Masaki and Isshin to Begin May 31
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
ELBIT SYSTEMS REPORTS FIRST QUARTER 2024 RESULTS
-
European Journalists to Explore Industry-Transforming Innovation at World's Top EV Laboratory
-
CEA & Dawex Create a Joint Research & Development Laboratory to Advance Innovation in Industries
-
Resolution Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2024
-
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
-
Ensurge Micropower ASA - Disclosure of Large Shareholdings
-
Basin Uranium Announces Submission of Permit at South Pass
-
Gladiator Extends Cowley Park Geological Model to Include Additional High-Grade Copper Mineralization
-
LIFT intersects 33 m at 1.09% Li2O at its Echo pegmatite, Yellowknife Lithium Project, NWT
-
Edge Total Intelligence Inc. Updates Status of MCTO
-
Pixalate Accelerates Growth in Asia-Pacific: Announces New Singapore Office, Strategic Partnerships with ByteDance Ad Network Pangle, Opera, Pubmatic, TCL FFalcon & WebEye Ad Platform TaurusX
-
Genovate Announces Plans to Submit a New Drug Application for PMR to the U.S. Food & Drug Administration in the Second Half of 2025
-
indent, inc., Operator of Largest Creative Platform Nola, Appoints Yui Tsutsumi as Chief "Isekai" Officer, or Independent Director


